Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19
Clinical trial NCT05679492 · WITHDRAWN
Trial details
- NCT number
- NCT05679492
- Sponsor
- Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2023-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.